Combining Left Atrial Appendage Closure With Cryoballoon Ablation in Chinese Population

NCT04185142 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-10-03

No results posted yet for this study

Summary

Cryoablation combined with left atrial appendage closure is a novel strategy for atrial fibrillation patients. Through long-term follow-up, the investigators aimed to observe the safety and efficacy of the combined procedure in Chinese population.

Conditions

Interventions

COMBINATION_PRODUCT

cryoballoon ablation combining with left atrial appendage closure

cryoballoon ablation using either 1st or 2nd generation of cryoballoon and left atrial appendage closure using devices including WATCHMAN, Lefort and Lacbes.

Sponsors & Collaborators

  • Shanghai 10th People's Hospital

    lead OTHER

Principal Investigators

  • Yawei Xu, MD, PhD · Department of Cardiology, Shanghai Tenth People's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-16
Primary Completion
2023-11-16
Completion
2024-11-16

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04185142 on ClinicalTrials.gov